Suppr超能文献

怡康胶囊治疗膀胱过度活动症的疗效和耐受性。

Efficacy and Tolerability of Ich Nieu Khang Dietary Supplement for Overactive Bladder.

机构信息

Geriatric Department, Hanoi Hospital of Traditional Medicine, Hanoi, Vietnam.

Department of Traditional Medicine, Hanoi Medical University, Hanoi, Vietnam.

出版信息

J Med Food. 2023 Apr;26(4):262-269. doi: 10.1089/jmf.2022.0085.

Abstract

This study aims to assess the effectiveness and safety of plant-derived food supplement Ich Nieu Khang (INK) as a dietary supplement for overactive bladder (OAB) symptoms. A total of 50 patients 18-80 years of age with the diagnosis and symptoms of the OAB were enrolled in the study and followed up for 30 days. The INK treatment efficacy, in terms of changes in nocturnal and day-time urination frequency, urination incontinence episodes, level of OAB symptoms according to Homma's OABSS scale, sleep quality according to Pittsburg Sleep Quality Index (PSQI), and possible side effects of the INK phytotherapy, was evaluated. INK significantly improved all OAB symptoms scores with a reduction of average nocturia from 4.06 ± 1.53 to 1.14 ± 0.94, the daily average urination urgency from 7.67 ± 5.00 to 5. 82 ± 3.70, the daily average frequency of urination from 9.96 ± 4.04 to 8.00 ± 3.70, weekly average incontinence of urination from 0.92 ± 1.56 to 0.60 ± 1.02, and OABSS Homma's score decreased from 9.31 ± 1.44 to 6.8 ± 2.21. INK phytotherapy also resulted in sleep quality improvement by PSQI score decreasing from 13.11 ± 1.33 to 10.54 ± 2.21. There were no adverse effects and abnormalities in paraclinical parameters with INK therapy. The results of our study suggest that INK dietary supplement is effective and safe phytotherapy for patients with primary OAB symptoms within 30 days of treatment. Larger control clinical trials are warranted to confirm our findings and promote wider use of INK for OAB and possible other age-related urination disorders.

摘要

本研究旨在评估植物源性食品补充剂 Ich Nieu Khang(INK)作为治疗膀胱过度活动症(OAB)症状的膳食补充剂的有效性和安全性。共有 50 名年龄在 18-80 岁之间的 OAB 诊断和症状患者入组本研究,并随访 30 天。根据 Homma 的 OABSS 量表评估 INK 治疗疗效,包括夜间和日间排尿频率、排尿失禁发作次数、OAB 症状水平、匹兹堡睡眠质量指数(PSQI)评估的睡眠质量以及 INK 植物疗法的可能副作用。INK 显著改善了所有 OAB 症状评分,平均夜尿次数从 4.06±1.53 减少至 1.14±0.94,每日平均尿急次数从 7.67±5.00 减少至 5.82±3.70,每日平均排尿频率从 9.96±4.04 减少至 8.00±3.70,每周平均失禁排尿次数从 0.92±1.56 减少至 0.60±1.02,Homma 的 OABSS 评分从 9.31±1.44 降低至 6.8±2.21。INK 植物疗法还通过 PSQI 评分从 13.11±1.33 降低至 10.54±2.21 改善了睡眠质量。INK 治疗没有导致不良影响和临床参数异常。我们的研究结果表明,INK 膳食补充剂是一种有效的治疗原发性 OAB 症状的植物疗法,在 30 天的治疗后效果显著。需要更大的对照临床试验来证实我们的发现,并促进 INK 在 OAB 和可能其他与年龄相关的排尿障碍中的更广泛应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2900/10124173/90e28ec412e7/jmf.2022.0085_figure1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验